JPMorgan Chase & Co’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $122K | Buy |
|
|||||
|
2025
Q1 | $15.1K | Sell |
|
|||||
|
2024
Q4 | $131K | Sell |
|
|||||
|
2024
Q3 | $262K | Buy |
|
|||||
|
2024
Q2 | $16.7K | Sell |
|
|||||
|
2024
Q1 | $94K | Buy |
|
|||||
|
2023
Q4 | $1.2K | Sell |
|
|||||
|
2023
Q3 | $102K | Buy |
|
|||||
|
2023
Q2 | $2.75K | Hold |
|
|||||
|
2023
Q1 | $1K | Hold |
|
|||||
|
2022
Q4 | $1K | Sell |
|
|||||
|
2022
Q3 | $2K | Buy |
|
|||||
|
2022
Q2 | $2K | Sell |
|
|||||
|
2022
Q1 | $9K | Buy |
|
|||||
|
2021
Q4 | $10K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $226K | Sell |
|
|||||
|
2019
Q1 | $673K | Sell |
|
|||||
|
2018
Q4 | $841K | Buy |
|
|||||
|
2018
Q3 | $1.01M | Buy |
|
|||||
|
2018
Q2 | $1.26M | Sell |
|
|||||
|
2018
Q1 | $2.52M | Sell |
|
|||||
|
2017
Q4 | $2.54M | Sell |
|
|||||
|
2017
Q3 | $5.11M | Sell |
|
|||||
|
2017
Q2 | $4.03M | Buy |
|
|||||
|
2017
Q1 | $3.2M | Sell |
|
|||||
|
2016
Q4 | $2.58M | Buy |
|
|||||
|
2016
Q3 | $2.71M | Sell |
|
|||||
|
2016
Q2 | $2.5M | Buy |
|